 As of 2016, among the top ten generic drugs manufacturing companies worldwide, Pfizer Established Pharma was the leading one based on company value. According to the given source, Pfizer Established Pharma (today: Essential Health) was valued at 84.6 billion U.S. dollars at that time. Hengrui was valued at some 13.2 billion U.S. dollars and was at the bottom of the top 10 generics companies during that year. Generic pharmaceutical companies In general, the U.S. generic pharmaceutical industry has seen significant growth in recent years. Certain players have shown to hold a bigger presence in the industry. Among the top 10 pharmaceutical companies by U.S. unbranded generics revenue in 2016-2017, Fresenius Kabi generated the least revenue and Teva generated the most revenue. Among all pharmaceutical companies (including non-generic), Pfizer was projected to be the top revenue generating company in the coming years based on prescription drug revenues worldwide. Generic prescription drugs in the U.S. The proportion of generic prescription drugs dispensed in the United States has increased dramatically over the last years. Increased generic usage has caused significant cost savings to the U.S. health system. Among all generic drugs available in the United States, the availability of atorvastatin (the generic form of Lipitor) has generated the most health cost savings in 2017. 